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Profilins constitute a family of highly conserved pro-
teins, which are present in all eukaryotic cells and are
involved in processes related to cell motility. The first
allergenic profilin was described in birch pollen and was
designated Bet v 2.
Allergenic profilin were identified in tree and grass
pollens, in weeds, in plant-derived foods, as well as in
latex. Due to conserved structure of the profilins, speci-
fic IgE may cross-react with homologues from virtually
every plant source. Therefore, profilin sensitization is a
risk factor for allergic reactions to multiple pollen and
food allergen sources.
Profilins are randomly distributed in pulp and peel and
they are labile to heat denaturation and pepsin digestion.
In fact the ingestion of vegetables in profilin sensitized
patients usually determines reactions restricted to the oral
cavity (oral allergy syndrome, OAS), despite in literature
systemic reactions to zucchini and litches are reported.
We describe the history of six patients with adverse
reactions after eating plant-derived food and positive
allergological evaluation (skin tests, specific IgE, basophil
activation test and double-blind placebo-control chal-
lenges (DBPCFC) for profilin, that have been undergone
to desensitization treatment.
The protocol of desensitization started with a drop of
profilin solution (50 µg/ml) diluted 1:1018 in water until the
highest dose of 10 drops of undiluted solution three times a
week. They underwent this desensitization treatment at
home and were followed in Day Hospital regimen monthly.
According to the protocol they were trained in medical
treatment of allergic reactions and equipped with an emer-
gency kit: autoinjectable epinephrine, betamethasone and
clorphenamine. At the end of the treatment all patients
had negative DBPCFCs with culprit foods and a decrease
of specific IgE levels for profilin and vegetable foods.
Moreover, the desensitization with profilin has proved to
be safe as no serious adverse events were observed in our
patients. Profilin desensitization allowed that our patients
could manage their diet without restriction, eating several
foods previously not tolerated.
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